Richard E. Uihlein, Director, 10% Owner at GALECTIN THERAPEUTICS INC (GALT), bought 20,700 shares at $4.82 ($100K) on 2019-04-09, disclosed to the SEC on 2019-04-09.
Open-market purchase of $100k GALT by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| GALT | BUY | 2019-04-08 | $202K | — | Filing → |
| GALT | BUY | 2019-01-31 | $251K | — | Filing → |